The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice
daily for 48 weeks reduces structural lung disease as assessed by computed tomography (CT) in
comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 6)
with cystic fibrosis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Washington, the Collaborative Health Studies Coordinating Center
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics